Valley National Advisers’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21K | Buy |
773
+14
| +2% | +$380 | ﹤0.01% | 477 |
|
|
2025
Q1 | $21K | Buy |
759
+365
| +93% | +$10.1K | ﹤0.01% | 479 |
|
|
2024
Q4 | $16K | Hold |
394
| – | – | ﹤0.01% | 478 |
|
|
2024
Q3 | $26K | Sell |
394
-90
| -19% | -$5.94K | ﹤0.01% | 423 |
|
|
2024
Q2 | $57K | Buy |
484
+20
| +4% | +$2.36K | 0.01% | 373 |
|
|
2024
Q1 | $49K | Sell |
464
-48
| -9% | -$5.07K | 0.01% | 403 |
|
|
2023
Q4 | $50K | Sell |
512
-26
| -5% | -$2.54K | 0.01% | 402 |
|
|
2023
Q3 | $56K | Buy |
538
+2
| +0.4% | +$208 | 0.01% | 372 |
|
|
2023
Q2 | $66K | Buy |
536
+9
| +2% | +$1.11K | 0.01% | 357 |
|
|
2023
Q1 | $73K | Buy |
527
+100
| +23% | +$13.9K | 0.01% | 335 |
|
|
2022
Q4 | $79K | Buy |
427
+48
| +13% | +$8.88K | 0.01% | 331 |
|
|
2022
Q3 | $51K | Buy |
379
+4
| +1% | +$538 | 0.01% | 374 |
|
|
2022
Q2 | $65K | Buy |
375
+46
| +14% | +$7.97K | 0.01% | 321 |
|
|
2022
Q1 | $57K | Buy |
329
+88
| +37% | +$15.2K | 0.01% | 351 |
|
|
2021
Q4 | $61K | Buy |
241
+37
| +18% | +$9.37K | 0.01% | 334 |
|
|
2021
Q3 | $79K | Buy |
204
+6
| +3% | +$2.32K | 0.01% | 302 |
|
|
2021
Q2 | $47K | Buy |
198
+12
| +6% | +$2.85K | 0.01% | 353 |
|
|
2021
Q1 | $24K | Buy |
186
+13
| +8% | +$1.68K | ﹤0.01% | 424 |
|
|
2020
Q4 | $18K | Sell |
173
-50
| -22% | -$5.2K | ﹤0.01% | 451 |
|
|
2020
Q3 | $16K | Hold |
223
| – | – | ﹤0.01% | 428 |
|
|
2020
Q2 | $14K | Sell |
223
-174
| -44% | -$10.9K | ﹤0.01% | 443 |
|
|
2020
Q1 | $12K | Buy |
+397
| New | +$12K | ﹤0.01% | 449 |
|